EUDA Health Limited, established in 2019, is a Singapore-based enterprise dedicated to advancing digital healthcare. It provides an innovative platform facilitating online medical consultations for routine, non-urgent health concerns. This entity functions as a subsidiary of Watermark Developments Limited.
An institutional-grade, numbers-driven thesis on EUDA — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of July 4, 2026, TradersQuant's model rates EUDA Health Holdings Limited (EUDA) 54/100 with a 12-month base-case forecast of $13.39 — -3.5% versus the current price of $13.88. EUDA Health Holdings Limited trades at $13.88 in the Healthcare sector, with a market capitalisation of $25.9M. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month TradersQuant model price target for EUDA is $13.39, implying -3.5% versus the current price. The model's 12-month scenario range runs from $12.07 (bear) to $15.40 (bull), with a base case of $13.39.
On the fundamentals, EUDA Health Holdings Limited shows a P/E of -15.5, trailing revenue of $6.8M, revenue growth of +70.0% YoY. This page also tracks EUDA's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
EUDA currently carries a TradersQuant composite score of 54/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "Buy". Our 12-month price target of $13.39 implies -3.5% from $13.88. This is research, not financial advice — always combine it with your own judgement.
The TradersQuant 12-month model price target for EUDA is $13.39, about -3.5% versus the latest price of $13.88. Consensus is based on 1 analysts.
TradersQuant's 12-month model forecast for EUDA is a base case of $13.39, ranging from $12.07 (bear) to $15.40 (bull), an expected return of -3.5%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for EUDA over the next 12 months is $13.39 in the base case (bear $12.07, bull $15.40), versus today's price of $13.88. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for EUDA — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates EUDA's fair value at $17.62, implying +27.0% of expected upside versus the current price.
EUDA Health Holdings Limited does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
